Resveratrol is one of the more legally uncomplicated supplement ingredients on the market. It's not a controlled substance, it's not a prescription medication, and it has a long history of being sold over the counter as a dietary supplement. That said, the regulatory framework that governs how it can be sold and what claims sellers can make about it is more involved than most readers realize.
This article walks through the legal status of resveratrol across major markets, what restrictions actually exist, and why the regulatory category matters for what you should expect from a product label.
In the U.S., resveratrol is regulated as a dietary supplement under the Dietary Supplement Health and Education Act of 1994 (DSHEA). This means:
The FDA can take enforcement action against products that are unsafe or that make impermissible drug claims, but unlike pharmaceutical regulation, there's no pre-market approval gate.
In the EU, the regulatory situation is more interesting. Trans-resveratrol from Polygonum cuspidatum (Japanese knotweed) was authorized as a Novel Food in 2016, which means it's legal to sell but with specific conditions on dose and labeling. Maximum daily intake is restricted to 150 mg/day from this source for the general adult population, with stricter limits for pregnant and breastfeeding women.
The 150 mg/day cap is meaningfully lower than what's used in most U.S.-based clinical research. EU consumers who want higher-dose resveratrol typically import from outside the EU or use grape-derived extracts, which fall under different rules.
The UK initially retained EU Novel Food rules after Brexit. UK Food Standards Agency policy currently mirrors the EU 150 mg/day cap from Japanese knotweed sources. Imports from outside the EU/UK can be subject to customs review.
Health Canada regulates resveratrol as a natural health product. Products require a Natural Product Number (NPN) and must meet labeling and safety standards. The regulatory burden is more rigorous than U.S. dietary supplement rules but less so than EU Novel Food regulations. Maximum allowed daily doses are typically in the 200–500 mg range, depending on the source and intended use.
Therapeutic Goods Administration (TGA) regulates supplements as "complementary medicines." Resveratrol products typically need to be entered on the Australian Register of Therapeutic Goods (ARTG) before sale. Daily-dose limits are generally not as restrictive as the EU but more controlled than the U.S.
Regulatory frameworks vary widely:
Some clarifications worth making explicit:
For most readers, the regulatory situation looks like this:
Resveratrol is legal across all major markets. Where the markets differ is in how strictly they limit doses and what manufacturers can claim. None of this changes the underlying biology — the molecule is the same everywhere — but it does affect what you'll find on shelves and what label claims you can trust.
None of the above is legal advice. Regulations change; if you're importing or operating commercially, verify current rules in your jurisdiction. For a product-level breakdown, see our methodology and top 10 reviews.
More on resveratrol from our editorial team.